The structure and location of SIMP/STT3B account for its prominent imprint on the MHC I immunopeptidome

International Immunology

Volumn 17, Issue 12, 2005, Pages 1583-1596

  Caron, Étienne ^a   Charbonneau, Renée ^a   Huppé, Gabrielle ^a   Brochu, Sylvie ^a   Perreault, Claude ^a  

^a INSTITUTE FOR RESEARCH IN IMMUNOLOGY AND CANCER   (Canada)

Author keywords

Antigen presentation; Cell trafficking; Major histocompatibility complex; Peptides; Vaccination

Indexed keywords

LYSINE; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MEMBRANE PROTEIN; OVALBUMIN; PROTEASOME; PROTEOME; SOURCE OF IMMUNODOMINANT MHC ASSOCIATED PEPTIDE PROTEIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ANTIGEN PRESENTATION; ARTICLE; CELLULAR DISTRIBUTION; CONTROLLED STUDY; ENDOPLASMIC RETICULUM; HUMAN; HUMAN CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN FOLDING; PROTEIN LOCALIZATION; PROTEIN STRUCTURE;

ANIMALS; ANTIGEN PRESENTATION; AUTOANTIGENS; CD8-POSITIVE T-LYMPHOCYTES; CERCOPITHECUS AETHIOPS; COS CELLS; ENDOPLASMIC RETICULUM; GLYCOSYLTRANSFERASES; HELA CELLS; HISTOCOMPATIBILITY ANTIGENS CLASS I; HUMANS; MICE; PROTEIN FOLDING; PROTEOME;

EID: 28744440862     PISSN: 09538178     EISSN: 14602377     Source Type: Journal    
DOI: 10.1093/intimm/dxh336     Document Type: Article

References (69)

1. Pamer, E. and Cresswell, P. 1998. Mechanisms of MHC class I-restricted antigen processing. Annu. Rev. Immunol. 16:323.
2. Yewdell, J. W. and Bennink, J. R. 2001. Cut and trim: Generating MHC class I peptide ligands. Curr. Opin. Immunol. 13:13.
3. Rock, K. L., York, I. A., Saric, T. and Goldberg, A. L. 2002. Protein degradation and the generation of MHC class I-presented peptides. Adv. Immunol. 80:1.
4. Goldrath, A. W. and Bevan, M. J. 1999. Selecting and maintaining a diverse T-cell repertoire. Nature 402:255.
5. Perreault, C., Décary, F., Brochu, S., Gyger, M., Bélanger, R. and Roy, D. 1990. Minor histocompatibility antigens. Blood 76:1269.
6. Simpson, E. and Roopenian, D. 1997. Minor histocompatibility antigens. Curr. Opin. Immunol. 9:655.
7. Boon, T. and van der Bruggen, P. 1996. Human tumor antigens recognized by T lymphocytes. J. Exp. Med. 183:725.
8. Engelhard, V., Brickner, A. and Zarling, A. 2002. Insights into antigen processing gained by direct analysis of the naturally processed class I MHC associated peptide repertoire. Mol. Immunol. 39:127.
9. Hickman, H. D., Luis, A. D., Buchli, R. et al. 2004. Toward a definition of self: Proteomic evaluation of the class I peptide repertoire. J. Immunol. 172:2944.
10. Pion, S., Fontaine, P., Desaulniers, M., Jutras, J., Filep, J. G. and Perreault, C. 1997. On the mechanisms of immunodominance in cytotoxic T lymphocyte responses to minor histocompatibility antigens. Eur. J. Immunol. 27:421.
11. Pion, S., Christianson, G. J., Fontaine, P., Roopenian, D. C. and Perreault, C. 1999. Shaping the repertoire of cytotoxic T-lymphocyte responses: Explanation for the immunodominance effect whereby cytotoxic T lymphocytes specific for immunodominant antigens prevent recognition of nondominant antigens. Blood 93:952.
12. Fontaine, P., Roy-Proulx, G., Knafo, L., Baron, C., Roy, D. C. and Perreault, C. 2001. Adoptive transfer of T lymphocytes targeted to a single immunodominant minor histocompatibility antigen eradicates leukemia cells without causing graft-versus-host disease. Nat. Med. 7:789.
13. dom1 minor histocompatibility antigen is encoded by a mouse homolog of the yeast STT3 gene. Immunogenetics 54:562.
14. Hirokawa, T., Boon-Chieng, S. and Mitaku, S. 1998. SOSUI: Classification and secondary structure prediction system for membrane proteins. Bioinformatics 14:378.
15. Kelleher, D. J., Karaoglu, D., Mandon, E. C. and Gilmore, R. 2003. Oligosaccharyltransferase isoforms that contain different catalytic STT3 subunits have distinct enzymatic properties. Mol. Cell 12:101.
16. Nilsson, I., Kelleher, D. J., Miao, Y. et al. 2003. Photocross-linking of nascent chains to the STT3 subunit of the oligosaccharyltransferase complex. J. Cell Biol. 161:715.
17. Schubert, U., Anton, L. C., Gibbs, J., Norbury, C. C., Yewdell, J. W. and Bennink, J. R. 2000. Rapid degradation of a large fraction of newly synthesized proteins by proteasomes. Nature 404:770.
18. Reits, E. A., Vos, J. C., Grommé, M. and Neefjes, J. 2000. The major substrates for TAP in vivo are derived from newly synthesized proteins. Nature 404:774.
19. Yewdell, J. W. 2003. Immunology. Hide and seek in the peptidome. Science 301:1334.
20. Shastri, N., Schwab, S. and Serwold, T. 2002. Producing nature's gene-chips: The generation of peptides for display by MHC class I molecules. Annu. Rev. Immunol. 20:463.
21. Ostankovitch, M., Robila, V. and Engelhard, V. H. 2005. Regulated folding of tyrosinase in the endoplasmic reticulum demonstrates that misfolded full-length proteins are efficient substrates for class I processing and presentation. J. Immunol. 174:2544.
22. Yewdell, J. W. 2003. Hide and seek in the peptidome. Science 301:1334.
23. Kessler, B., Hong, X., Petrovic, J. et al. 2003. Pathways accessory to proteasomal proteolysis are less efficient in major histocompatibility complex class I antigen production. J. Biol. Chem. 278: 10013.
24. Wojcik, C. and DeMartino, G. N. 2003. Intracellular localization of proteasomes. Int. J. Biochem. Cell Biol. 35:579.
25. Anton, L. C., Schubert, U., Bacik, I. et al. 1999. Intracellular localization of proteasomal degradation of a viral antigen. J. Cell Biol. 146:113.
26. Lacaille, V. G. and Androlewicz, M. J. 2000. Targeting of HIV-1 Nef to the centrosome: Implications for antigen processing. Traffic 1:884.
27. Brooks, P., Murray, R. Z., Mason, G. G., Hendil, K. B. and Rivett, A. J. 2000. Association of immunoproteasomes with the endoplasmic reticulum. Biochem. J. 352(Pt 3):611.
28. Reits, E., Griekspoor, A., Neijssen, J. et al. 2003. Peptide diffusion, protection and degradation in nuclear and cytoplasmic compartments before antigen presentation by MHC class I. Immunity 18:97.
29. Sitia, R. and Braakman, I. 2003. Quality control in the endoplasmic reticulum protein factory. Nature 426:894.
30. Porgador, A., Yewdell, J. W., Deng, Y., Bennink, J. R. and Germain, R. N. 1997. Localization, quantitation, and in situ detection of specific peptide-MHC class I complexes using a monoclonal antibody. Immunity 6:715.
31. Yewdell, J. W., Reits, E. and Neefjes, J. 2003. Making sense of mass destruction: Quantitating MHC class I antigen presentation. Nat. Rev. Immunol. 3:952.
32. Yewdell, J. W., Schubert, U. and Bennink, J. R. 2001. At the crossroads of cell biology and immunology: DRiPs and other sources of peptide ligands for MHC class I molecules. J. Cell Sci. 114:845.
33. Illing, M. E., Rajan, R. S., Bence, N. F. and Kopito, R. R. 2002. A rhodopsin mutant linked to autosomal dominant retinitis pigmentosa is prone to aggregate and interacts with the ubiquitin proteasome system. J. Biol. Chem. 277:34150.
34. Karaoglu, D., Kelleher, D. J. and Gilmore, R. 1997. The highly conserved Stt3 protein is a subunit of the yeast oligosaccharyl-transferase and forms a subcomplex with Ost3p and Ost4p. J. Biol. Chem. 272:32513.
35. Vashist, S. and Ng, D. T. 2004. Misfolded proteins are sorted by a sequential checkpoint mechanism of ER quality control. J. Cell Biol. 165:41.
36. Johnston, J. A., Ward, C. L. and Kopito, R. R. 1998. Aggresomes: A cellular response to misfolded proteins. J. Cell Biol. 143:1883.
37. Raposo, G., van Santen, H. M., Leijendekker, R., Geuze, H. J. and Ploegh, H. L. 1995. Misfolded major histocompatibility complex class I molecules accumulate in an expanded ER-Golgi intermediate compartment. J. Cell Biol. 131:1403.
38. Cox, J. S., Chapman, R. E. and Walter, P. 1997. The unfolded protein response coordinates the production of endoplasmic reticulum protein and endoplasmic reticulum membrane. Mol. Biol. Cell 8:1805.
39. Sriburi, R., Jackowski, S., Mori, K. and Brewer, J. W. 2004. XBP1: A link between the unfolded protein response, lipid biosynthesis, and biogenesis of the endoplasmic reticulum. J. Cell Biol. 167:35.
40. Szczesna-Skorupa, E., Chen, C. D., Liu, H. and Kemper, B. 2004. Gene expression changes associated with the endoplasmic reticulum stress response induced by microsomal cytochrome P450 overproduction. J. Biol. Chem. 279:13953.
41. Huyer, G., Longsworth, G. L., Mason, D. L. et al. 2004. A striking quality control subcompartment in Saccharomyces cerevisiae: The endoplasmic reticulum-associated compartment (ERAC). Mol. Biol. Cell 15:908.
42. Kamhi-Nesher, S., Shenkman, M., Tolchinsky, S., Fromm, S. V., Ehrlich, R. and Lederkremer, G. Z. 2001. A novel quality control compartment derived from the endoplasmic reticulum. Mol. Biol. Cell 12:1711.
43. Glickman, M. H. and Ciechanover, A. 2002. The ubiquitin-proteasome proteolytic pathway: Destruction for the sake of construction. Physiol. Rev. 82:373.
44. Cuervo, A. M. 2004. Autophagy: In sickness and in health. Trends Cell Biol. 14:70.
45. Storkus, W. J., Zeh, H. J., Salter, R. D. and Lotze, M. T. 1993. Identification of T-cell epitopes: Rapid isolation of class I-presented peptides from viable cells by mild acid elution. J. Immunother. 14:94.
46. Mosse, C. A., Meadows, L., Luckey, C. J. et al. 1998. The class I antigen-processing pathway for the membrane protein tyrosinase involves translation in the endoplasmic reticulum and processing in the cytosol. J. Exp. Med. 187:37.
47. Lilley, B. N. and Ploegh, H. L. 2004. A membrane protein required for dislocation of misfolded proteins from the ER. Nature 429:834.
48. Jarosch, E., Geiss-Friedlander, R., Meusser, B., Walter, J. and Sommer, T. 2002. Protein dislocation from the endoplasmic reticulum - pulling out the suspect. Traffic 3:530.
49. Elkabetz, Y., Shapira, I., Rabinovich, E. and Bar-Nun, S. 2004. Distinct steps in dislocation of luminal endoplasmic reticulum-associated degradation substrates: Roles of endoplamic reticulum-bound p97/Cdc48p and proteasome. J. Biol. Chem. 279:3980.
50. Helenius, A. and Aebi, M. 2004. Roles of N-linked glycans in the endoplasmic reticulum. Annu. Rev. Biochem. 73:1019.
51. Spear, E. D. and Ng, D. T. 2005. Single, context-specific glycans can target misfolded glycoproteins for ER-associated degradation. J. Cell Biol. 169:73.
52. Fruh, K. and Yang, Y. 1999. Antigen presentation by MHC class I and its regulation by interferon g. Curr. Opin. Immunol. 11:76.
53. Princiotta, M. F., Finzi, D., Qian, S. B. et al. 2003. Quantitating protein synthesis, degradation, and endogenous antigen processing. Immunity 18:343.
54. Dickson, K. M., Bergeron, J. J. M., Shames, I. et al. 2002. Association of calnexin with mutant peripheral myelin protein-22 ex vivo: A basis for 'gain-of-function' ER diseases. Proc. Natl Acad. Sci. USA 99:9852.
55. Okiyoneda, T., Harada, K., Takeya, M. et al. 2004. ÄF508 CFTR pool in the ER is increased by calnexin overexpression. Mol. Biol. Cell 15:563.
56. Lee, R. J., Liu, C. W., Harty, C. et al. 2004. Uncoupling retrotranslocation and degradation in the ER-associated degradation of a soluble protein. EMBO J. 23:2206.
57. Catic, A., Collins, C., Church, G. M. and Ploegh, H. L. 2004. Preferred in vivo ubiquitination sites. Bioinformatics 20:3302.
58. Janse, D. M., Crosas, B., Finley, D. and Church, G. M. 2004. Localization to the proteasome is sufficient for degradation. J. Biol. Chem. 279:21415.
59. Begley, G. S., Horvath, A. R., Taylor, J. C. and Higgins, C. F. 2005. Cytoplasmic domains of the transporter associated with antigen processing and P-glycoprotein interact with subunits of the proteasome. Mol. Immunol. 42:137.
60. Kesmir, C., van Noort, V., de Boer, R. J. and Hogeweg, P. 2003. Bioinformatic analysis of functional differences between the immunoproteasome and the constitutive proteasome. Immunogenetics 55:437.
61. Klein, J. and Nikolaidis, N. 2005. The descent of the antibody-based immune system by gradual evolution. Proc. Natl Acad. Sci. USA 102:169.
62. Brewer, J. W. and Hendershot, L. M. 2005. Building an antibody factory: a job for the unfolded protein response. Nat. Immunol. 6:23.
63. Nil, A., Firat, E., Sobek, V., Eichmann, K. and Niedermann, G. 2004. Expression of housekeeping and immunoproteasome subunit genes is differentially regulated in positively and negatively selecting thymic stroma subsets. Eur. J. Immunol. 34:2681.
64. Morel, S., Lévy, F., Burlet-Schiltz, O. et al. 2000. Processing of some antigens by the standard proteasome but not by the immunoproteasome results in poor presentation by dendritic cells. Immunity 12:107.
65. Desjardins, M. 2003. ER-mediated phagocytosis: A new membrane for new functions. Nat. Rev. Immunol. 3:280.
66. Ackerman, A. L. and Cresswell, P. 2004. Cellular mechanisms governing cross-presentation of exogenous antigens. Nat. Immunol. 5:678.
67. Golovina, T. N., Wherry, E. J., Bullock, T. N. and Eisenlohr, L. C. 2002. Efficient and qualitatively distinct MHC class I-restricted presentation of antigen targeted to the endoplasmic reticulum. J. Immunol. 168:2667.
68. Golovina, T. N., Morrison, S. E. and Eisenlohr, L. C. 2005. The impact of misfolding versus targeted degradation on the efficiency of the MHC class I-restricted antigen processing. J. Immunol. 174:2763.
69. Tewari, M. K., Sinnathamby, G., Rajagopal, D. and Eisenlohr, L. C. 2005. A cytosolic pathway for MHC class II-restricted antigen processing that is proteasome and TAP dependent. Nat. Immunol. 6:287.